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Background: The aim of the study is to compare the outcome of phacoemulsification in patients with and without
pseudoexfoliation syndrome in Kashmir.
Methods: 200 patients were prospectively evaluated and divided into 2 groups. Group 1 comprised 100 cases with
pseudoexfoliation and Group 2 (control) 100 cases without pseudoexfoliation. Phacoemulsification with posterior
chamber intraocular lens implantation was performed by 3 surgeons. Intraoperative and postoperative observations
were made in both the groups at regular intervals upto 6 months. A chi square test was used for statistical analysis.
Results: Patients with pseudoexfoliation were significantly older (P = 0.000), had harder cataract(P = 0.030) and
smaller mean pupil diameter(P = 0.000) than the control group. Intraoperative complications were comparable
between the 2 groups except the occurrence of zonular dehiscence which was seen in 7% patients of Group 1
compared to 0% in Group 2. Higher postoperative inflammatory response was seen in Group 1(P = 0.000). Decrease
in intraocular pressure (IOP) at all postoperative measurements was more in Group 1(P = 0.000). The visual acuity
was better in the control group in the early postoperative period (P = 0.029), however the final visual acuity at
6 months was comparable between the 2 groups.
Conclusions: Phacoemulsification in presence of pseudoexfoliation necessitates appropriate surgical technique to
avoid intraoperative complications. Pseudoexfoliation is associated with higher inflammatory response, significant
postoperative IOP drop and satisfactory visual outcome.Background
The Pseudoexfoliation(PEX) syndrome is a systemic dis-
order of unknown etiology and is associated with an
increased incidence of intraoperative complications [1].
In PEX syndrome, lysosomal proteinases destroy the
normal basement membrane structure of the non-
pigmented epithelium of the ciliary body and anterior
lens capsule which loosens the zonule-lens capsule
complex and causes adhesions between the zonules and
non-pigmented epithelium [1,2]. The rotational and
posterior forces created during nucleus emulsification
may lead to total separation of these weakened zonules,
resulting in vitreous loss. Other factors thought to* Correspondence: aalia.sufi@gmail.com
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reproduction in any medium, provided the orcontribute to the increased incidence of intraoperative
complications during cataract surgery in eyes with PEX
syndrome are poorly dilating pupils, corneal endothelial
changes and blood-aqueous barrier breakdown [3–8].
We designed a prospective study to evaluate the results
of phacoemulsification in patients of Kashmiri origin,
with and without pseudoexfoliation syndrome.Methods
This case control study was conducted prospectively
between 2006–2008 in the Postgraduate Department of
Ophthalmology, Government Medical College, Srinagar,
Kashmir, India. 200 patients were divided into two
groups: Group 1 comprised 100 cases with pseudoexfo-
liation and Group 2 (control) 100 cases without
pseudoexfoliation.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Glaucoma, subluxation of the lens, conditions predispos-
ing to zonular weakness and increased inflammatory
response postoperatively, uveitis, history of trauma, his-
tory of intraocular surgical procedure, corneal pathologies,
complicated cataract, retinal pathology like age related
macular degeneration(ARMD), diabetic retinopathy, ret-
inal detachment; all the conditions that would influence
the outcome of visual acuity following surgery were
excluded from our study.
Complete clinical evaluation was done including age,
sex, visual acuity with Snellen chart, intra-ocular pres-
sure (IOP) by Goldmann applanation tonometry(AT)
and fundus examination. Detailed slit lamp biomicro-
scopy under maximal mydriasis was performed to assess
the type and grade of cataract, and presence of phaco-
donesis or zonulolysis. Diagnosis of PEX was based on
the presence of fibrillin deposits on the pupillary margin,
anterior lens capsule, or both. Intraocular lens (IOL)
power calculation was done with SRK II formula.
Patients were admitted one day prior to surgery and
were prescribed topical antibiotics one hourly. Pupil was
dilated with cyclopentolate 1%, tropicamide 1%, phenyl-
ephrine 10% and dilatation was maintained with flurbi-
profen 0.03%. All patients provided informed consent.
Surgical technique
Phacoemulsification surgery was performed in all eyes
under peribulbar/posterior subtenon anesthesia by 3
experienced surgeons.
After creation of a superior incision and filling of the
anterior chamber with a viscoelastic substance, continu-
ous curvilinear capsulorhexis was performed with a capsu-
lotomy needle or a capsulotomy forcep. In case of poor
pupillary dilatation, iris hooks were used or the pupil was
stretched mechanically. Hydrodisection was performed to
loosen capsule cortical attachments. Phacoemulsification
of the lens nucleus was performed. The lens cortex was
aspirated, the capsular bag was filled with a viscoelastic
material and a one –piece polymethyl methacrylate pos-
terior chamber foldable intra ocular lens (5.5-6 mm optic)
was implanted in the uneventful cases. In cases with pos-
terior capsule rupture (PCR) or zonular dehiscence (ZD),
the IOL was implanted in the sulcus after anterior vitrec-
tomy. In one case of zonular dialysis, a capsular tension
ring (CTR) was used.
Intra operative complications documented were: pos-
terior capsule rupture, phacodonesis, zonular dehiscence
and vitreous loss(VL).
Postoperative observations made were: IOP measure-
ment, early postoperative complications like striate
keratopathy(SK), corneal edema, anterior chamber flare
and cell response, fibrin in the anterior chamber, pos-
terior synechiae, inflammatory membrane, any capsularchange- i.e. capsular contraction or opacification and
visual acuity.
Patients were prescribed topical antibiotic steroids
(dexamethasone 0.1% or prednisolone 1% and ofloxacin
0.3%) one hourly for the first week and then tapered grad-
ually over a period of four to six weeks. Mydriatic in the
form of tropicamide 1% was prescribed if the need arose.
Post operative follow up examinations were conducted
on day one, two weeks, four weeks, six weeks and six
months under a definite proforma by the same observer.
Best corrected visual acuity(BCVA) was assessed at six
months. Fundus examination was done and reason for
poor visual acuity,if any, was looked into.Data processing and analysis
Statistical analysis of the data was done by using chi-
square test (χ2 test) without or with Yates correction as
and when required. The level of significance was fixed at
P-value less than 0.05 i.e. P< 0.05 was taken to be statis-
tically significant.Results
In our study, the mean age of patients with PEX was
significantly higher (P= 0.000) than those in the control
group that is 76% of cases with PEX were older than
60 years of age compared to 27% of cases of control .
There was a statistical difference in the sex distribution,
with male predominance, 68% of patients with PEX were
males as compared to 51% in the control group
(P= 0.014). Slit lamp assessment showed that combined
form of cataract (cortical changes with nuclear changes
with varying degree of posterior sub capsular cataract)
was the predominant form of cataract operated in our
study in either group. However patients with PEX had
harder cataract with nuclear sclerosis≥ grade 3(P= 0.030).
73% patients of Group 1 showed PEX material on the
pupillary margin only and 27% showed PEX both on the
pupillary margin and a central disc on the anterior lens
capsule. Our study showed a highly significant difference
in the preoperative pupillary dilatation in response to
mydriatics between the two groups (Table 1).
In our study, the rates of PCR and VL were compar-
able in both the groups. PCR occurred in 7%, VL in 2%
cases of Group 1 and 8% and 1% in Group 2 respect-
ively, however, the rate of ZD was greater (7%) in the
PEX group whereas no patient in the control group
developed ZD. In 6% patients with PEX, lens was
implanted in the sulcus compared to 2% in the control
group (Table 2). Capsular tension ring (CTR) was
implanted in one patient with PEX who developed ZD
intraoperatively, in order to stabilize the bag.
More eyes in Group 1 had a significantly (P = 0.00)
higher postoperative inflammatory response in the form
Table 1 Distribution of patients on the basis of Pre-
operative Pupil Dilatation
Pupil PEX Control Total
Dilatation Frequency Frequency Frequency
Max(>= 5 mm) 10 95 105
Mid(3-5 mm) 85 5 90
Min(<3 mm) 5 0 5
Total 100 100 200
χ2 ¼ 144:921; P ¼ 0:000; p < 0:05; Highly Significant
Observations: The difference in the preoperative pupil diameter after
maximal mydriasis was highly significant between the two groups, with 85%
eyes with PXE attaining pupil size between 3 to 5 mm whereas 95% eyes of
the control group with pupil>=5 mm.








Clear pseudophakia 32 72 104
SK 22 22 44
Flare 30 1 31
Corneal Edema 12 3 15
Corneal burn 0 1 1
Hyphaema 0 1 1
inflammatory membrane 4 0 4
Total 100 100 200
χ2 ¼ 46:154P ¼ 0:000; p < 0:05; Highly Significant
Observations: Eyes with PEX had greater inflammatory reaction with 30%
having flare, 12% having corneal edema compared to 1% and 3% of the
control group respectively. Result was statistically significant.
Table 4 Distribution of patients according to IOP at
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tory membrane (Table 3).
Early development of posterior capsule haze was seen in
2% of eyes with PEX as compared to 0% in the control
group. At 4 weeks, the occurrence of posterior capsular
opacity (PCO) had increased with 4% PCO in group I
compared to 1% in group 2. However at 6 months, slit
lamp examination revealed that the frequency of PCO was
8% in the cases with PEX and 4% in patients of the control
group. The difference was not significant statistically. In
our study, we noted that at presentation, 45% patients of
Group 1 had IOP 18–20 mmHg whereas 69% patients of
Group 2 had IOP in the range of 16–18 mmHg. However
there was a significant decrease in IOP documented in the
PEX group at 6 months postoperatively; 92% cases of the
PEX group recorded an IOP <16 mmHg compared to
68% of the control group (Table 4).
In the early postoperative period at two weeks, there
was a statistically significant difference in the uncor-
rected visual acuity (UCVA) between the two groups
(P = 0.029). However the difference in the UCVA at
6 months was not found to be statistically significant.








PCR 7 8 15
SF lens 6 2 8
ZD 7 0 7
VL 2 1 3
No lens implanted 1 1 2
Total 23 12 35
χ2 ¼ 5:573P ¼ 0:134;p > 0:05; Not significant
Observations: As per intraoperative complications, there was no statistical
difference between the two groups However, comparison of ZD and SF lens
showed highly significant difference between the groups.better in 97% cases of the control group and 94% of
cases with PEX (Table 5).Discussion
Pseudoexfoliation Syndrome was first described by Lind-
berg in 1917 [9]. Several studies have reported differences
between eyes with and without PEX. Our study was aimed
at documenting this difference in patients from Kashmir.
Significantly more eyes in Group 1 had hard cataract i.e.
Grade 3 to Grade 4. Also the nuclei were found to be
harder intraoperatively at the time of phacoemulsification
than the preoperative LOCS III classification. This was
consistent with the study of Shastri and Vasavada [10].
We noted higher preoperative IOP in patients with PEX.
This was consistent with previous studies – Shingleton







8-10 8 0 8
10-12 9 1 10
12-14 34 21 55
14-16 41 46 87
16-18 5 29 34
18-20 2 3 4
20-22 0 0 0
22=> 1 0 0
Total 100 100 100
χ2 ¼ 35:90; p ¼ 0:000;p < 0:05 Significant
Observations: The difference in intraocular pressure was found highly
significant between the two groups. 92% of the cases with PEX had
IOP< 16 mm Hg as compared to 68% cases of the control group.
Table 5 Distribution according to BCVA at 6 months
Visual Acuity° PEX Control Total
Frequency Frequency Frequency
≤6/60 2 1 3
6/36-6/24 4 2 10
6/18-6/12 22 14 47
≥6/9-6/6 72 83 140
Total 100 100 200
χ 2 ¼ 3:558P ¼ 0:313; p > 0:05 Not significant
Observations: The BCVA between the two groups was comparable, with 72%
of PEX cases having BCVA ≥ 6/9 as compared to 83% of cases in control group.
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the control group.
A good mydriatic pupil is one of the main require-
ments for a safe and successful phacoemulsification sur-
gery. This is even more important in eyes with PEX
syndrome, in which surgery is more complicated be-
cause of the risks associated with loss of zonular integ-
rity and poor pupillary dilatation [13]. In our study, the
mean pupil diameter achieved after maximal mydriasis
was significantly less in the PEX Group. This necessi-
tated the use of iris hooks, mechanical pupil stretching
and viscomydriasis to facilitate surgical maneuvers.
Cataract surgery in eyes with PEX syndrome is consid-
ered a challenge because of weakened zonules and poor
pupillary dilatation. Initial case reports document increased
rate of complications during cataract extraction in patients
with PEX syndrome. Drolsum and co-authors [14] found a
frequency of 9.6% of capsular tear, zonular tear or vitreous
loss in eyes with PEX. In the study by Shingleton and co-
authors [11], the rate of vitreous loss was 4% in the PEX
eyes and 0% in non-PEX group.
However recent reports by Shastri and Vasavada [10],
Michael Hyams et al. [15] and others report no significant
difference in the rate of complications between patients
with and without PEX. Raymond J. Nagashima [16]
reported no cases of posterior capsular tears and zonulo-
dialysis. In our study, though intraoperative complications
were comparable between the two groups, the occurrence
of zonular dehiscence and sulcus fixated lens was more in
Group 1.
Various factors that explain the difference between our
intraoperative result and the lesser complications in the re-
cent reports are:
1. Surgical experience being a crucial factor.
Comparatively we are in the initial phase of
phacoemulsification. It is to be stressed here that the
rate of complications was more in patients operated
in the earlier part of our study whereas it was
significantly less in the later part of the study. We
attributed this to the increasing experience ofsurgeons which acted as a crucial factor when
operating on eyes with PEX.
2. With experience we learnt that gentle multi-quadrant
hydrodissection with very gentle in-the-bag nuclear
rotation is advocated to avoid zonular stress and
dehiscence in PEX cases.
3. It was also found that rather than doing in-the- bag
nucleotomy with its inherent danger of further
damaging the already weak zonules, it is safer to do a
supra-capsular pulsed phaco with soft shell visco-
technique to protect the corneal endothelium after
dividing the nucleus into two halves as the stress on
the zonules by this technique is much less, and all the
maneuvers therein are outside the bag reducing any
stress on the zonules.
4. Michael Hyams et al. [15] implanted an anterior
chamber IOL in higher number of patients with
PEX. This may act as a surrogate for complications.
5. Also degree of PEX was not graded in any of the
studies. It was observed in grading the degree of
PEX, intraoperative complications were seen more
in cases with severe exfoliation i.e. PEX present on
the lens capsule and zonules.
We noted a higher inflammatory response postopera-
tively in patients with PEX in the form of flare, cells,
corneal edema and inflammatory membranes. The signifi-
cantly higher postoperative inflammatory response in
patients with PEX can be attributed to the transient break-
down of the blood-aqueous barrier that occurs during pha-
coemulsification in patients with PEX [17]. In addition iris
vessels are pathological with an increased permeability for
protein in eyes with PEX [18].
The literature has shown a decrease in IOP after phacoe-
mulsification that is more pronounced in eyes with a higher
preoperative IOP. It is speculated that phacoemulsification
removes a source of PEX material (the anterior lens cap-
sule) and results in or stimulates clearance of PEX and pig-
ment debris from the anterior segment, in particular the
trabecular meshwork [12]. This was supported by other
studies by DJ Cimetta [19] and Shingleton [11]. Our study
too showed a decrease in IOP after phacoemulsification
which was more pronounced in patients with PEX than in
controls thus being consistent with other studies.
The UCVA in the early postoperative period was sig-
nificantly better in the control group as compared to the
group with PEX. This was attributed to the higher post-
operative inflammatory response which affected the vis-
ual acuity in patients with PEX. However the UCVA
later was comparable between the two groups. This was
attributed to the clearance of inflammatory reaction that
had caused a significant drop in visual acuity previously.
Though the difference in BCVA at 6 months between
the two groups was not statistically significant yet visual
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currence of posterior capsular haze and opacity which
was more in this group. This was consistent with Akinci
et al. [20] and Shastri and Vasavada [10] who reported no
significant difference in the visual acuity gain between the
two groups (p> 0.05). However Streho M [21] reported a
mean postoperative visual acuity of 0.4±0.6 LogMar in the
PEX group and 0.2±0.1 LogMar in the control group.
Drolsum et al. [14] reported a visual acuity of 0.5 (6/12) or
better achieved in 86.5% of eyes with PEX and 92.4% in
control group (P=0.02) at 4 months.
Conclusions
PEX with cataract is a challenging situation with prob-
able higher intraoperative complications as compared to
other cataracts due to weak zonules, poor pupillary dila-
tation and harder nuclei.
Certain preoperative and intraoperative measures are im-
perative like the availability of iris hooks, CTR, good gentle
complete hydrodissection, gentle in-the- bag nuclear rota-
tion and preferably a supracapsular nucleatomy using a
soft shell visco-technique and pulsed phaco power to avoid
any inbag stress.
Keeping the above points in view, we found that pha-
coemulsification is safe and effective in eyes with PEX. It
is associated with a significant postoperative drop in IOP.
However, there is, in our view, significant postoperative
inflammatory reaction in patients with PEX that affects
the visual status in the early postoperative period. Also
there is increased posterior capsular opacification in some
of these cases. However, the final visual outcome was
comparable between the two groups.
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